ERBB2 and breast carcinoma: With the development of “omics” (transcriptomic and genomic) technology, breast cancers were classified into the following five intrinsic subtypes (PAM50) by analyzing their gene expression pattern rather than the receptor expression status: basal-like, luminal A or B, HER2-enriched, or normal-like [2,3,7].